EUCTR2011-005344-95-DK
Active, not recruiting
Phase 1
Time course of the blood pressure lowering effect of liraglutide therapy in type 2 diabetes - Liratime
DrugsVictoza
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Steno Diabetes Center
- Status
- Active, not recruiting
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Must give written informed consent before participation. Patient information and consent form must be approved by the Danish Medicines Agency and the Regional Scientific Ethical Committee
- •2\.Male or female patients \>18 years with type 2 diabetes (WHO criteria).
- •3\.Patients must be on treatment with metformin. Any form of treatment with SU compounds will be discontinued and washed out for two weeks prior to the start of study drug.
- •4\.HbA1c \> 6\.5%
- •5\.eGFR \= 60 ml/min/1\.73 m2 (estimated by MDRD formula)
- •6\.Fertile female patients must use chemical, hormonal and mechanical contraceptives or be in menopause (i.e. must not have had regular menstrual bleeding for at least one year) or have undergone bilateral oophorectomi or have been surgically sterilized or hysterectomised at least six months prior to screening
- •7\.Patients must be on antihypertensive treatment or having elevated blood pressure (SBP \=130 mm Hg and DBP \=80 mmHg), lower than 170/105 mm Hg at baseline and the patients must be stable antihypertensive medication for at least 4 weeks prior to baseline
- •8\.Patients must be on stable hypoglycemic medication for at least two weeks before the first visit.
- •9\.Must be able to communicate with the investigator
- •Are the trial subjects under 18? no
Exclusion Criteria
- •1\.Ongoing insulin therapy
- •2\.BP \> 170/105 mm Hg at baseline
- •3\.Type 1 diabetes mellitus
- •4\.Chronic pancreatitis / previous acute pancreatitis
- •5\.Known or suspected hypersensitivity to trial product(s) or related products.
- •6\.Treatment with oral glucocorticoids, calcineurin inhibitors, or dipeptidyl peptidase 4 (DPP4\) inhibitors which in the Investigator’s opinion could interfere with glucose or lipid metabolism 90 days prior to screening
- •7\.Cancer (except basal cell skin cancer or squamous cell skin cancer) or any other clinically significant disorder, except for conditions associated with type 2 diabetes history, which in the investigators opinion could interfere with the results of the trial
- •8\.Inflammatory bowel disease
- •9\.Cardiac disease defined as: Decompensated heart failure (NYHA class III\-IV) and/or diagnosis of unstable angina pectoris and/or myocardial infarction within the last 6 months
- •10\.Previous bowel resection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Short-term effects on blood pressure of reducing nitrate metabolism using antibacterial mouthwash in treated hypertensive individualsACTRN12613000417785The University of Western Australia25
Completed
Not Applicable
Study on the effect of blood pressure suppression by single intake of test foodsHealthy AdultsJPRN-UMIN000053620Healthcare Systems Co., Ltd.4
Recruiting
Not Applicable
The relationship between blood pressure reduction by standing and respiratory muscleJPRN-UMIN000028450Kochi University40
Completed
Phase 2
The Effect of Blood Pressure improvement on memory function of Senior Citizens with Low Blood Pressure and mild memory impairment.CTRI/2014/12/005298KMC MANGALORE MANIPAL UNIVERSITY80
Completed
Not Applicable
Study of effect of blood pressure suppression by intake of MekabuHealthy AdultsJPRN-UMIN000046597Healthcare Systems Co., Ltd.60